Haleos Labs Limited

Haleos Labs Limi showed improved financial performance in Mar'25, with net sales rising to 344.72 Cr and profit after tax increasing to 18.73 Cr, up from 6.33 Cr in the previous year. The company also reported enhanced operational efficiency, reflected in a significant rise in operating profit to 49.90 Cr.

On 21-Nov, SMS Lifesciences India Ltd witnessed a significant rise in its share price, closing at ₹1,418.20 with a gain of ₹92.5 or 6.98%. This upward momentum reflects a combination of robust financial results, favourable valuation metrics, and heightened investor participation, positioning the stock well above key moving averages and outperforming broader market benchmarks.

SMS Lifesciences showed improved financial performance in Mar'25, with net sales rising to 344.72 Cr and profit before tax increasing to 26.19 Cr, despite a decline from Mar'22 levels. The company also reported a significant rise in operating profit margin and earnings per share, indicating a recovery in profitability and operational efficiency.

As of 14-Nov, SMS Lifesciences India Ltd is currently priced at 1,311.00, reflecting a 4.29% increase and strong performance over the past week. Despite impressive returns and outperformance against the Sensex, a significant drop in delivery volume raises concerns about the sustainability of this price increase.

SMS Lifesciences has shown fluctuating historical performance, with net sales increasing to 344.72 Cr in March 2025, alongside significant growth in profits, including a profit before tax rise to 26.19 Cr. The company has demonstrated improved operational efficiency and positive cash flow trends in recent years.

SMS Lifesciences' latest results show a 30.62% year-on-year profit growth to ₹6.10 crores and improved operating margins, but revenue declined slightly, indicating challenges in sales growth and below-average return on equity. Overall, the performance is mixed, suggesting a complex financial environment for the company.

As of 03-Nov, SMS Lifesciences India Ltd is priced at Rs 1,212.00, showing a recent upward trend with a 5.94% return over the last three days. Despite short-term gains, the stock has underperformed the Sensex year-to-date and over the past year.

As of 26-Sep, SMS Lifesciences India Ltd's stock price has declined to 1,145.00, down 4.15%, and is significantly underperforming its sector and the overall market. The stock shows weak fundamentals, with a low ROCE of 9.00% and a year-over-year return of -22.74%, contributing to declining investor confidence.

As of 22-Sep, SMS Lifesciences India Ltd is seeing a price increase to Rs 1,227.00, with a 1-week return of 1.91% and a 1-month return of 5.78%. Despite recent gains, the stock has weak long-term fundamentals and declining profit trends, indicating mixed market conditions.

As of 18-Sep, SMS Lifesciences India Ltd is priced at Rs 1,223.95, having increased by 1.57% today, but it has declined 19.34% over the past year. The stock shows strong short to medium-term trends, although investor participation has decreased, and its year-to-date return lags behind the Sensex.

As of 17-Sep, SMS Lifesciences India Ltd's stock price is 1,205.00, down 0.43%, and has underperformed its sector today. Despite recent positive returns, the stock has a troubling one-year return of -22.18%, indicating ongoing challenges and negative investor sentiment.

As of 16-Sep, SMS Lifesciences India Ltd is priced at 1,210.20, with recent short-term gains but a concerning long-term decline of 23.41% over the past year. Despite outperforming the Sensex recently, the stock's fundamentals are weak, indicating potential risks ahead.

As of 15-Sep, SMS Lifesciences India Ltd is currently priced at 1,204.00, reflecting a recent increase but a significant decline of 25.32% over the past year. While the stock shows positive short-term momentum, its long-term outlook remains cautious due to weak fundamentals and declining profits.

As of 11-Sep, SMS Lifesciences India Ltd is currently priced at Rs 1,209.00, reflecting a 5.13% increase today and a positive trend reversal. Despite short-term gains, the stock has underperformed over the past year, facing significant long-term challenges.

As of 18-Aug, SMS Lifesciences India Ltd's stock price is Rs 1,074.30, down 0.53%, and has underperformed its sector. The stock is in a bearish trend, trading below all key moving averages, with a year-to-date return of -10.62% and a significant decline in profits and investor confidence.